# clm_A9BE529B3D7A

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_research_and_development  
value: 529,749,000 United States dollar  
valid_from: 2017-09-30  
valid_to: 2018-03-31  
published: 2017-11-08  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_4BE823A99904  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly research and development: 529,749,000 United States dollar", as of 2017-09-30 (until 2018-03-31). Claim clm_A9BE529B3D7A, https://asof.is/claim/clm_A9BE529B3D7A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217617000034/0001532176-17-000034-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2017, filed 2017-11-08  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217617000034/0001532176-17-000034-index.htm (primary, SEC EDGAR 10-Q Q3 FY2017, published 2017-11-08)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 509,975,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_A9BE529B3D7A](/claim/clm_A9BE529B3D7A.md) | [clm_F6A5C3C217BB](/claim/clm_F6A5C3C217BB.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.